Cargando…
Vaccination against the human cytomegalovirus
The human cytomegalovirus (HCMV) is the most important infectious cause of congenital abnormalities and also of infectious complications of transplantation. The biology of the infection is complex and acquired immunity does not always prevent reinfection. Nevertheless, vaccine development is far adv...
Autores principales: | Plotkin, Stanley A., Boppana, Suresh B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892274/ https://www.ncbi.nlm.nih.gov/pubmed/29622379 http://dx.doi.org/10.1016/j.vaccine.2018.02.089 |
Ejemplares similares
-
Antiviral Treatment of Maternal and Congenital Cytomegalovirus (CMV) Infections
por: Pinninti, Swetha, et al.
Publicado: (2023) -
Human cytomegalovirus glycoprotein N polymorphisms among renal transplant recipients in India
por: Patro, A Raj Kumar, et al.
Publicado: (2014) -
Development of novel vaccines against human cytomegalovirus
por: Cui, Xinle, et al.
Publicado: (2019) -
Sang Froid in a time of trouble: is a vaccine against HIV possible?
por: Plotkin, Stanley A
Publicado: (2009) -
417. Cytomegalovirus (CMV) and Sexually Transmitted infections (STIs) During Pregnancy
por: Geetha Pinninti, Swetha, et al.
Publicado: (2019)